Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

N. Takigawa; K. Kiura; Y. Segawa; Y. Watanabe; H. Kamei; T. Moritaka; T. Shibayama; H. Ueoka; K. Gemba; T. Yonei; M. Tabata; T. Shinkai; S. Hiraki; M. Takemoto; Susumu Kanazawa; K. Matsuo; Mitsune Tanimoto

doi:10.1038/sj.bjc.6603422

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

N. Takigawa, K. Kiura, Y. Segawa, Y. Watanabe, H. Kamei, T. Moritaka, T. Shibayama, H. Ueoka, K. Gemba, T. Yonei, M. Tabata, T. Shinkai, S. Hiraki, M. Takemoto, Susumu Kanazawa, K. Matsuo, Mitsune Tanimoto

University Hospital

Research output: Contribution to journal › Article › peer-review

25 Citations (Scopus)

Abstract

Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).

Original language	English
Pages (from-to)	1142-1144
Number of pages	3
Journal	British Journal of Cancer
Volume	95
Issue number	9
DOIs	https://doi.org/10.1038/sj.bjc.6603422
Publication status	Published - Nov 6 2006

Keywords

Chemotherapy
Non-small-cell lung cancer
Radiotherapy
Second primary cancer

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/sj.bjc.6603422

Cite this

Takigawa, N., Kiura, K., Segawa, Y., Watanabe, Y., Kamei, H., Moritaka, T., Shibayama, T., Ueoka, H., Gemba, K., Yonei, T., Tabata, M., Shinkai, T., Hiraki, S., Takemoto, M., Kanazawa, S., Matsuo, K., & Tanimoto, M. (2006). Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer. British Journal of Cancer, 95(9), 1142-1144. https://doi.org/10.1038/sj.bjc.6603422

Takigawa, N, Kiura, K, Segawa, Y, Watanabe, Y, Kamei, H, Moritaka, T, Shibayama, T, Ueoka, H, Gemba, K, Yonei, T, Tabata, M, Shinkai, T, Hiraki, S, Takemoto, M, Kanazawa, S, Matsuo, K & Tanimoto, M 2006, 'Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer', British Journal of Cancer, vol. 95, no. 9, pp. 1142-1144. https://doi.org/10.1038/sj.bjc.6603422

@article{1b196259db83414c8def48e0cc0fe249,

title = "Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer",

abstract = "Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).",

keywords = "Chemotherapy, Non-small-cell lung cancer, Radiotherapy, Second primary cancer",

author = "N. Takigawa and K. Kiura and Y. Segawa and Y. Watanabe and H. Kamei and T. Moritaka and T. Shibayama and H. Ueoka and K. Gemba and T. Yonei and M. Tabata and T. Shinkai and S. Hiraki and M. Takemoto and Susumu Kanazawa and K. Matsuo and Mitsune Tanimoto",

year = "2006",

month = nov,

day = "6",

doi = "10.1038/sj.bjc.6603422",

language = "English",

volume = "95",

pages = "1142--1144",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

AU - Takigawa, N.

AU - Kiura, K.

AU - Segawa, Y.

AU - Watanabe, Y.

AU - Kamei, H.

AU - Moritaka, T.

AU - Shibayama, T.

AU - Ueoka, H.

AU - Gemba, K.

AU - Yonei, T.

AU - Tabata, M.

AU - Shinkai, T.

AU - Hiraki, S.

AU - Takemoto, M.

AU - Kanazawa, Susumu

AU - Matsuo, K.

AU - Tanimoto, Mitsune

PY - 2006/11/6

Y1 - 2006/11/6

N2 - Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).

AB - Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).

KW - Chemotherapy

KW - Non-small-cell lung cancer

KW - Radiotherapy

KW - Second primary cancer

UR - http://www.scopus.com/inward/record.url?scp=33750482212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750482212&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6603422

DO - 10.1038/sj.bjc.6603422

M3 - Article

C2 - 17031394

AN - SCOPUS:33750482212

SN - 0007-0920

VL - 95

SP - 1142

EP - 1144

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 9

ER -

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this